CNMD

SEC source: 0000816956-25-000061 · form4.xml · derivative · entry 3

Glaze Richard · CIK 0002025615 · Chief Information Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 750

Underlying: Common Stock · 375 shares

Expires 2033-11-20

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · derivative.exercise_date: Represents the settlement of vested restricted stock units (RSUs) with the delivery of shares of common stock, subject to withholding for taxes. Each RSU represents a contingent right to receive one share of common stock, par value $0.01 per share of ConMed Corporation.

SEC source: 0000816956-25-000061 · form4.xml · nonDerivative · entry 2

Glaze Richard · CIK 0002025615 · Chief Information Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 257

SEC source: 0000816956-25-000061 · form4.xml · nonDerivative · entry 1

Glaze Richard · CIK 0002025615 · Chief Information Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 375

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

SEC source: 0000816956-25-000059 · form4.xml · nonDerivative · entry 1

Garner Todd W · CIK 0001726884 · Executive Vice President & CFO

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 1,836

SEC source: 0000816956-25-000053 · form4.xml · derivative · entry 3

Foust Hollie K · CIK 0002043157 · General Counsel & Corp Sec

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 4,000

Underlying: Common Stock · 4,000 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · derivative.exercise_price: Each restricted stock unit ("RSU") represents a contingent right to receive one share of common stock, par value $0.01 per share of CONMED Corporation (the "Company").

F2 · derivative.exercise_date: The RSUs are subject to the terms and conditions of the Company's 2018 Long-Term Incentive Plan vesting over two years with 50% vesting after year 1 and 50% vesting after year 2.

F2 · derivative.expiration_date: The RSUs are subject to the terms and conditions of the Company's 2018 Long-Term Incentive Plan vesting over two years with 50% vesting after year 1 and 50% vesting after year 2.

SEC source: 0000816956-25-000053 · form4.xml · nonDerivative · entry 2

Foust Hollie K · CIK 0002043157 · General Counsel & Corp Sec

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 2,886

SEC source: 0000816956-25-000053 · form4.xml · nonDerivative · entry 1

Foust Hollie K · CIK 0002043157 · General Counsel & Corp Sec

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 4,000

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

SEC source: 0000816956-25-000044 · form4.xml · derivative · entry 3

Garner Todd W · CIK 0001726884 · Executive Vice President & CFO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 15,227

Underlying: Common Stock · 7,500 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · derivative.exercise_price: Each restricted stock unit ("RSU") represents a contingent right to receive one share of common stock, par value $0.01 per share of CONMED Corporation (the "Company").

F2 · derivative.exercise_date: The RSUs are subject to the terms and conditions of the Company's 2018 Long-Term Incentive Plan vesting over two years with 33% vesting after year 1 and 67% vesting after year 2.

F2 · derivative.expiration_date: The RSUs are subject to the terms and conditions of the Company's 2018 Long-Term Incentive Plan vesting over two years with 33% vesting after year 1 and 67% vesting after year 2.

SEC source: 0000816956-25-000044 · form4.xml · nonDerivative · entry 2

Garner Todd W · CIK 0001726884 · Executive Vice President & CFO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 5,336

SEC source: 0000816956-25-000044 · form4.xml · nonDerivative · entry 1

Garner Todd W · CIK 0001726884 · Executive Vice President & CFO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 7,500

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

SEC source: 0000816956-25-000042 · form4.xml · nonDerivative · entry 2

Farkas Charles · CIK 0001615538 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 14,859

SEC source: 0000816956-25-000042 · form4.xml · nonDerivative · entry 1

Farkas Charles · CIK 0001615538 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 15,756

SEC source: 0000816956-25-000040 · form4.xml · derivative · entry 2

Kelderman Kim · CIK 0001739054 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 6,227

Underlying: Common Stock · 6,227 shares

Expires 2035-09-08

F2 · ownership.direct: The stock options were granted under the 2025 Long-Term Incentive Plan of CONMED Corporation (the "Company) and generally vest 100% 1 year from the grant date.

SEC source: 0000816956-25-000040 · form4.xml · derivative · entry 1

Kelderman Kim · CIK 0001739054 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 500

Underlying: Common Stock · 500 shares

Expires 2035-09-08

F1 · ownership.direct: Each restricted stock unit ("RSU") represents a contingent right to receive one share of common stock, par value $0.01 per share of ConMed Corporation (the "Company") and will be subject to the terms and conditions of the Company's 2025 Long-Term Incentive Plan, with the RSUs generally vesting 100% after a one year period.

F2 · ownership.direct: The stock options were granted under the 2025 Long-Term Incentive Plan of CONMED Corporation (the "Company) and generally vest 100% 1 year from the grant date.

SEC source: 0000816956-25-000033 · form4.xml · nonDerivative · entry 1

Garner Todd W · CIK 0001726884 · Executive Vice President & CFO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 0

SEC source: 0001127602-25-016771 · form4.xml · derivative · entry 5

Schwarzentraub Barbara J · CIK 0001788466 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 479 shares

Expires 2034-06-03

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F3 · derivative.exercise_date: Each restricted stock unit ("RSU") represents a contingent right to receive one share of common stock, par value $0.01 per share of ConMed Corporation (the "Company") and will be subject to the terms and conditions of the Company's 2020 Amended and Restated Non-Employee Director Equity Compensation Plan, with the RSUs generally vesting 100% after a one year period with the RSU vesting immediately upon termination of the Director's service.

SEC source: 0001127602-25-016771 · form4.xml · nonDerivative · entry 1

Schwarzentraub Barbara J · CIK 0001788466 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 4,344

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

SEC source: 0001127602-25-016768 · form4.xml · derivative · entry 4

Concannon Brian · CIK 0001261784 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 479 shares

Expires 2034-06-03

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F3 · derivative.exercise_date: Each restricted stock unit ("RSU") represents a contingent right to receive one share of common stock, par value $0.01 per share of ConMed Corporation (the "Company") and will be subject to the terms and conditions of the Company's 2020 Amended and Restated Non-Employee Director Equity Compensation Plan, with the RSUs generally vesting 100% after a one year period with the RSU vesting immediately upon termination of the Director's service.

SEC source: 0001127602-25-016768 · form4.xml · nonDerivative · entry 1

Concannon Brian · CIK 0001261784 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 10,116

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

SEC source: 0001127602-25-016762 · form4.xml · derivative · entry 4

Farkas Charles · CIK 0001615538 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 479 shares

Expires 2034-06-03

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F3 · derivative.exercise_date: Each restricted stock unit ("RSU") represents a contingent right to receive one share of common stock, par value $0.01 per share of ConMed Corporation (the "Company") and will be subject to the terms and conditions of the Company's 2020 Amended and Restated Non-Employee Director Equity Compensation Plan, with the RSUs generally vesting 100% after a one year period with the RSU vesting immediately upon termination of the Director's service.

SEC source: 0001127602-25-016762 · form4.xml · nonDerivative · entry 1

Farkas Charles · CIK 0001615538 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 16,859

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

SEC source: 0001127602-25-016754 · form4.xml · derivative · entry 4

Bronson David M. · CIK 0001183762 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 479 shares

Expires 2034-06-03

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F3 · derivative.exercise_date: Each restricted stock unit ("RSU") represents a contingent right to receive one share of common stock, par value $0.01 per share of ConMed Corporation (the "Company") and will be subject to the terms and conditions of the Company's 2020 Amended and Restated Non-Employee Director Equity Compensation Plan, with the RSUs generally vesting 100% after a one year period with the RSU vesting immediately upon termination of the Director's service.

SEC source: 0001127602-25-016754 · form4.xml · nonDerivative · entry 1

Bronson David M. · CIK 0001183762 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 17,241

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

SEC source: 0001127602-25-016760 · form4.xml · derivative · entry 4

Council LaVerne H · CIK 0001788616 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 479 shares

Expires 2034-06-03

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F3 · derivative.exercise_date: Each restricted stock unit ("RSU") represents a contingent right to receive one share of common stock, par value $0.01 per share of ConMed Corporation (the "Company") and will be subject to the terms and conditions of the Company's 2020 Amended and Restated Non-Employee Director Equity Compensation Plan, with the RSUs generally vesting 100% after a one year period with the RSU vesting immediately upon termination of the Director's service.

SEC source: 0001127602-25-016760 · form4.xml · nonDerivative · entry 1

Council LaVerne H · CIK 0001788616 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 4,048

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

SEC source: 0001127602-25-016753 · form4.xml · derivative · entry 5

Aronson Martha Goldberg · CIK 0001429832 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 479 shares

Expires 2034-06-03

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F3 · derivative.exercise_date: Each restricted stock unit ("RSU") represents a contingent right to receive one share of common stock, par value $0.01 per share of ConMed Corporation (the "Company") and will be subject to the terms and conditions of the Company's 2020 Amended and Restated Non-Employee Director Equity Compensation Plan, with the RSUs generally vesting 100% after a one year period with the RSU vesting immediately upon termination of the Director's service.

SEC source: 0001127602-25-016753 · form4.xml · nonDerivative · entry 1

Aronson Martha Goldberg · CIK 0001429832 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 12,391

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

SEC source: 0001127602-25-016771 · form4.xml · derivative · entry 4

Schwarzentraub Barbara J · CIK 0001788466 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 668

Underlying: Common Stock · 668 shares

Expires 2035-06-02

F2 · derivative.exercise_date: Each restricted stock unit ("RSU") represents a contingent right to receive one share of common stock, par value $0.01 per share of ConMed Corporation (the "Company") and will be subject to the terms and conditions of the Company's 2025 Long-Term Incentive Plan, with the RSUs generally vesting 100% after a one year period with the RSU vesting immediately upon termination of the Director's service.

SEC source: 0001127602-25-016771 · form4.xml · derivative · entry 3

Schwarzentraub Barbara J · CIK 0001788466 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 8,061

Underlying: Common Stock · 8,061 shares

Expires 2035-06-02

F1 · derivative.exercise_date: The stock options were granted under the Company's 2025 Long-Term Incentive Plan and generally vest 100% after a one year period.

SEC source: 0001127602-25-016769 · form4.xml · derivative · entry 2

Kaye Mark · CIK 0001748691 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 668

Underlying: Common Stock · 668 shares

Expires 2035-06-02

F2 · derivative.exercise_date: Each restricted stock unit ("RSU") represents a contingent right to receive one share of common stock, par value $0.01 per share of ConMed Corporation (the "Company") and will be subject to the terms and conditions of the Company's 2025 Long-Term Incentive Plan, with the RSUs generally vesting 100% after a one year period with the RSU vesting immediately upon termination of the Director's service.

SEC source: 0001127602-25-016769 · form4.xml · derivative · entry 1

Kaye Mark · CIK 0001748691 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 8,061

Underlying: Common Stock · 8,061 shares

Expires 2035-06-02

F1 · derivative.exercise_date: The stock options were granted under the Company's 2025 Long-Term Incentive Plan and generally vest 100% after a one year period.

SEC source: 0001127602-25-016768 · form4.xml · derivative · entry 3

Concannon Brian · CIK 0001261784 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 668

Underlying: Common Stock · 668 shares

Expires 2035-06-02

F2 · derivative.exercise_date: Each restricted stock unit ("RSU") represents a contingent right to receive one share of common stock, par value $0.01 per share of ConMed Corporation (the "Company") and will be subject to the terms and conditions of the Company's 2025 Long-Term Incentive Plan, with the RSUs generally vesting 100% after a one year period with the RSU vesting immediately upon termination of the Director's service.

SEC source: 0001127602-25-016768 · form4.xml · derivative · entry 2

Concannon Brian · CIK 0001261784 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 8,061

Underlying: Common Stock · 8,061 shares

Expires 2035-06-02

F1 · derivative.exercise_date: The stock options were granted under the Company's 2025 Long-Term Incentive Plan and generally vest 100% after a one year period.

SEC source: 0001127602-25-016762 · form4.xml · derivative · entry 3

Farkas Charles · CIK 0001615538 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 668

Underlying: Common Stock · 668 shares

Expires 2035-06-02

F2 · derivative.exercise_date: Each restricted stock unit ("RSU") represents a contingent right to receive one share of common stock, par value $0.01 per share of ConMed Corporation (the "Company") and will be subject to the terms and conditions of the Company's 2025 Long-Term Incentive Plan, with the RSUs generally vesting 100% after a one year period with the RSU vesting immediately upon termination of the Director's service.

SEC source: 0001127602-25-016762 · form4.xml · derivative · entry 2

Farkas Charles · CIK 0001615538 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 8,061

Underlying: Common Stock · 8,061 shares

Expires 2035-06-02

F1 · derivative.exercise_date: The stock options were granted under the Company's 2025 Long-Term Incentive Plan and generally vest 100% after a one year period.

SEC source: 0001127602-25-016754 · form4.xml · derivative · entry 3

Bronson David M. · CIK 0001183762 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 668

Underlying: Common Stock · 668 shares

Expires 2035-06-02

F2 · derivative.exercise_date: Each restricted stock unit ("RSU") represents a contingent right to receive one share of common stock, par value $0.01 per share of ConMed Corporation (the "Company") and will be subject to the terms and conditions of the Company's 2025 Long-Term Incentive Plan, with the RSUs generally vesting 100% after a one year period with the RSU vesting immediately upon termination of the Director's service.

SEC source: 0001127602-25-016754 · form4.xml · derivative · entry 2

Bronson David M. · CIK 0001183762 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 8,061

Underlying: Common Stock · 8,061 shares

Expires 2035-06-02

F1 · derivative.exercise_date: The stock options were granted under the Company's 2025 Long-Term Incentive Plan and generally vest 100% after a one year period.

SEC source: 0001127602-25-016760 · form4.xml · derivative · entry 3

Council LaVerne H · CIK 0001788616 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 668

Underlying: Common Stock · 668 shares

Expires 2035-06-02

F2 · derivative.exercise_date: Each restricted stock unit ("RSU") represents a contingent right to receive one share of common stock, par value $0.01 per share of ConMed Corporation (the "Company") and will be subject to the terms and conditions of the Company's 2025 Long-Term Incentive Plan, with the RSUs generally vesting 100% after a one year period with the RSU vesting immediately upon termination of the Director's service.

SEC source: 0001127602-25-016760 · form4.xml · derivative · entry 2

Council LaVerne H · CIK 0001788616 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 8,061

Underlying: Common Stock · 8,061 shares

Expires 2035-06-02

F1 · derivative.exercise_date: The stock options were granted under the Company's 2025 Long-Term Incentive Plan and generally vest 100% after a one year period.

SEC source: 0001127602-25-016753 · form4.xml · derivative · entry 4

Aronson Martha Goldberg · CIK 0001429832 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 668

Underlying: Common Stock · 668 shares

Expires 2035-06-02

F2 · derivative.exercise_date: Each restricted stock unit ("RSU") represents a contingent right to receive one share of common stock, par value $0.01 per share of ConMed Corporation (the "Company") and will be subject to the terms and conditions of the Company's 2025 Long-Term Incentive Plan, with the RSUs generally vesting 100% after a one year period with the RSU vesting immediately upon termination of the Director's service.

SEC source: 0001127602-25-016753 · form4.xml · derivative · entry 3

Aronson Martha Goldberg · CIK 0001429832 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 8,061

Underlying: Common Stock · 8,061 shares

Expires 2035-06-02

F1 · derivative.exercise_date: The stock options were granted under the Company's 2025 Long-Term Incentive Plan and generally vest 100% after a one year period.

SEC source: 0001127602-25-016068 · form4.xml · derivative · entry 3

Farkas Charles · CIK 0001615538 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 1,000 shares

Expires 2025-06-01

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · derivative.exercise_date: The stock appreciation rights ("SARs") were granted under the Company's 2007 Non-Employee Director Equity Compensation Plan, with the SARs generally vesting 100% after a one year period.

SEC source: 0001127602-25-016068 · form4.xml · nonDerivative · entry 2

Farkas Charles · CIK 0001615538 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 16,380

SEC source: 0001127602-25-016068 · form4.xml · nonDerivative · entry 1

Farkas Charles · CIK 0001615538 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 17,346

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

SEC source: 0001127602-25-015194 · form4.xml · derivative · entry 2

Workman John L · CIK 0001302537 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 479 shares

Expires 2034-06-03

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · derivative.exercise_date: Each restricted stock unit ("RSU") represents a contingent right to receive one share of common stock, par value $0.01 per share of ConMed Corporation (the "Company") and will be subject to the terms and conditions of the Company's 2020 Amended and Restated Non-Employee Director Equity Compensation Plan, with the RSUs generally vesting 100% after a one year period with the RSU vesting immediately upon termination of the Director's service.

SEC source: 0001127602-25-015194 · form4.xml · nonDerivative · entry 1

Workman John L · CIK 0001302537 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 20,891

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

SEC source: 0001127602-25-013471 · form4.xml · nonDerivative · entry 1

Farkas Charles · CIK 0001615538 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 16,346

SEC source: 0001127602-25-012933 · form4.xml · derivative · entry 1

Schabacker Matthew · CIK 0002066553 · VP GM Advanced Surgical

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 31,675

Underlying: Common Stock · 31,675 shares

Expires 2035-04-28

F1 · derivative.exercise_date: The stock options were granted under the Company's 2018 Long-Term Incentive Plan and generally vest in equal amounts over a five year period

SEC source: 0001127602-25-011822 · form4.xml · nonDerivative · entry 1

Garner Todd W · CIK 0001726884 · Executive Vice President & CFO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 598

SEC source: 0001127602-25-009658 · form4.xml · derivative · entry 3

SHAGORY PETER K · CIK 0001398627 · EVP, STRAT & CORP DEVT

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 4,500 shares

Expires 2025-05-11

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · derivative.exercise_date: The stock appreciation rights ("SARs") were granted under the Company's 1999 Amended and Restated Long-Term Incentive Plan and generally vest in equal amounts over a five year period.